Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

Dell Technologies Capital has led a $30m series A round for machine learning technology developer Sima.ai that will use the money to accelerate production efforts.

6 Dimensions Capital led a round for mental health treatment portal Haoxinqing that will go to expanding the latter's R&D and partnership activities.

Biopharmaceutical firm Jubilant Life Sciences has licensed molecules with potential to fight cancer to a new venture formed with Frazier Healthcare Partners.

Medical data aggregation tool developer Owkin increased its series A round to $52m after an extension backed by existing investors GV, Eight Road Ventures and F-Prime Capital.

Alphabet has contributed to a $400m for Sidewalk Infrastructure Partners, a spinoff from the conglomerate’s smart cities technology subsidiary Sidewalk Labs.

Sales engagement software provider Groove has raised funding from a consortium that includes one of its customers, Capital One.

Each week, the Global Corporate Venturing Deal Net rounds up the week's smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.